Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
19%
OVERLAP
BY WEIGHT
23
# OF OVERLAPPING
HOLDINGS
WELS.DE
86
HOLDINGS
27%
ALSO IN EXV4.DE
EXV4.DE
60
HOLDINGS
55%
ALSO IN WELS.DE
SECTOR DRIFT (WELS.DE minus EXV4.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WELS.DE |
Weight in EXV4.DE |
Overlap | |
|---|---|---|---|---|
 |
ASTRAZENECA PLC | 4.6% | 15.1% | 4.6% |
 |
NOVARTIS AG | 4.1% | 14.4% | 4.1% |
 |
NOVO NORDISK A/S-B | 2.3% | 7.8% | 2.3% |
|
GSK PLC | 1.5% | 5.5% | 1.5% |
 |
SANOFI-AVENTIS | 1.5% | 5.4% | 1.5% |
WELS.DE Overweight Relative to EXV4.DE
 |
ELI LILLY & CO | 12.0% |
|
ABBVIE INC | 6.9% |
|
UNITEDHEALTH GROUP INC | 6.2% |
|
MERCK & CO. INC. | 4.8% |
|
AMGEN INC | 3.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
|
GILEAD SCIENCES INC | 2.7% |
|
INTUITIVE SURGICAL INC | 2.6% |
|
ABBOTT LABORATORIES | 2.3% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
WELS.DE Underweight Relative to EXV4.DE
|
ASTRAZENECA PLC | -10.6% |
|
NOVARTIS AG | -10.2% |
|
NOVO NORDISK A/S-B | -5.5% |
|
GSK PLC | -4.0% |
|
SANOFI-AVENTIS | -3.9% |
|
ESSILOR INTERNATIONAL | -2.6% |
 |
BAYER AG | -2.4% |
|
HALEON PLC | -2.2% |
|
SANDOZ GROUP AG | -2.0% |
 |
ARGEN-X SE | -1.9% |